Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations
previously not represented in Peripheral Vascular Disease (PVD) trials, health economics
data, and to support the safe use of commercially available Boston Scientific Corpor...
Age: 18 years - 66+
Gender: All
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry,
is to serve as an internationally collaborative, multicenter registry coordinated by an
experienced and centralized coordinating center in an effort to increase the pace of...
Age: 18 years - 66+
Gender: All
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants
with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.
Age: 18 years - 66+
Gender: All
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of
ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or
PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.
Age: 18 years - 66+
Gender: All
Defining the Basis of Fibromuscular Dysplasia (FMD)
The purpose of this study has evolved and expanded since its inception. Originally the intent
was to establish the functional, molecular and genetic profile of fibroblasts from
Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects....
Age: 18 years - 66+
Gender: All